NCT05363358 A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Status COMPLETED Phase N/A
NCT05353985 A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet Status COMPLETED Phase PHASE2
NCT05341128 A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China Status COMPLETED Phase N/A
NCT05341115 A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty Status COMPLETED Phase PHASE4
NCT05319353 A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) Status RECRUITING Phase PHASE3
NCT05316246 Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell Lymphoma Status UNKNOWN Phase PHASE2
NCT05309902 A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval Status WITHDRAWN Phase PHASE1
NCT05299359 A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19) Status COMPLETED Phase PHASE3
NCT05269082 A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults Status COMPLETED Phase N/A
NCT05265078 A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With Veyvondi Status COMPLETED Phase N/A
NCT05262023 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05220098 First-in-Human Study of TAK-280 in Participants With Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05187208 PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE4
NCT05183139 A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE4
NCT05180890 A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea Status COMPLETED Phase PHASE1